title: Commentary: Continuous infusion of vancomycin in neonates: to use or not to use remains the question.
authors.affiliation: From the *Departments of Pediatrics, Divisions of Neonatology and Pediatric Pharmacology, and Pharmacology/Toxicology, University of Utah, Salt Lake City, UT; †Neonatal Intensive Care Unit, University Hospitals Leuven; ‡Department of Development and Regeneration, Catholic University Leuven, Leuven, Belgium; §Department of Pediatrics, University Medical Center Nijmegen, the Netherlands; ¶Division of Pediatric Clinical Pharmacology, Children's National Medical Center; ‖Departments of Pediatrics, Pharmacology, Physiology and Integrative Systems Biology, George Washington University School of Medicine and Health Sciences, Washington, DC; and **Intensive Care, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
authors.forename: Robert M
authors.initials: RM
authors.lastname: Ward
authors.forename: Karel
authors.initials: K
authors.lastname: Allegaert
authors.forename: Ronald
authors.initials: R
authors.lastname: de Groot
authors.forename: Johannes N
authors.initials: JN
authors.lastname: van den Anker
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D006801:Humans; D014640:Vancomycin / Q000008:administration & dosage*
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin